Results 11 to 20 of about 25,474 (258)
Background Peritoneal dialysis (PD) is one of the most important kidney replacement therapies for patients with end‐stage kidney disease (ESKD). PD technique failure can lead to an escalated cost and increased infectious and cardiovascular risk, up and ...
Shuiqing He +9 more
doaj +1 more source
Continuous ambulatory peritoneal dialysis (CAPD) has been an effective treatment for end-stage renal disease (ESRD). Tuberculous peritonitis (TBP) in patients on CAPD is a perilous condition.
Andria Yuananda, Tjahjodjati
doaj +1 more source
Resumption of Peritoneal Dialysis Postpartum Following Pregnancy in an ESRD Patient: A Case Report and Literature Review. [PDF]
ABSTRACT Temporary transition from peritoneal to hemodialysis during pregnancy does not need to be permanent. When catheter patency and membrane function are preserved, peritoneal dialysis can be safely resumed postpartum. This case reinforces the importance of individualized, multidisciplinary dialysis management to optimize maternal and fetal ...
Matarneh A +7 more
europepmc +2 more sources
Educating end-stage renal disease patients on dialysis modality selection: a clinical advice from the European Renal Best Practice (ERBP) advisory board [PDF]
status ...
Bammens, Bert +7 more
core +2 more sources
Assessment and Management of Hypertension among Patients on Peritoneal Dialysis [PDF]
Approximately 7%-10% of patients with ESKD worldwide undergo peritoneal dialysis (PD) as kidney replacement therapy. The continuous nature of this dialytic modality and the absence of acute shifts in pressure and volume parameters is an important ...
Agarwal, Rajiv +3 more
core +1 more source
Comment on \u3ci\u3eSmall Bowel Necrosis\u3c/i\u3e [PDF]
Comment on the Article Small bowel necrosis associated with postoperative jejunal tube ...
Gervasio, Jane
core +2 more sources
Effect of high glucose concentration on the synthesis of monocyte chemoattractant protein-1 in human peritoneal mesothelial cells: Involvement of protein kinase C [PDF]
Human peritoneal mesothelial cells (HMC) contribute to the activation and control of inflammatory processes in the peritoneum by their potential to produce various inflammatory mediators.
Haslinger, Bettina +4 more
core +1 more source
With the increasing incidence of chronic kidney disease in Indonesia, an effective, sustainable and widely available kidney replacement therapy (KRT) is needed. PD is one of the available modalities that can meet those criteria.
Aida Lydia
doaj +1 more source
HDAC1 inhibition by MS-275 in mesothelial cells limits cellular invasion and promotes MMT reversal [PDF]
Peritoneal fibrosis is a pathological alteration of the peritoneal membrane occurring in a variety of conditions including peritoneal dialysis (PD), post-surgery adhesions and peritoneal metastases.
Battistelli, Cecilia +14 more
core +1 more source
Background: chronic kidney disease (CKD) is a major worldwide health problem. One key treatment for end-stage CKD patients is dialysis therapy such as Continuous Ambulatory Peritoneal Dialysis (CAPD).
Gede Wirya Kusuma Duarsa +8 more
doaj +2 more sources

